Live Chat

Negocie Gilead GILD

Venda
 Comprar

Gráfico Gilead ao vivo

5m 15m 30m 1h 4h 1d 1w

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

Info

Spread

0.57

Spread (%)

0.6213 %

Alavancagem

1:10

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Sexta-feira

14:31 - 20:59

Segunda-feira

14:31-20:59

Terça-feira

14:31-20:59

Quarta-feira

14:31-20:59

Quinta-feira

14:31-20:59

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

117585453056

Ações em circulação

1246000000

Data dos rendimentos (Próxima)

2013-01-28

Rendim Divid

2024-09-27

Data Ex-Dividendos

2024-12-13

Taxa anual futura de dividendos

3.08

Rendimento anual futuro de dividendos

0.0326

EPS

0.09

Saiba mais sobre este instrumento

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):

Negociar agora

Negociar agora

Negociar agora

Negociar agora
Instrumentos relacionados

Últimas notícias

Fique em dia com as últimas notícias financeiras pelo mundo afora.

Quinta-feira, 14 Novembro 2024

Dogecoin surges after Elon Musk issues crypto endorsement

Dogecoin surges

Quarta-feira, 13 Novembro 2024

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

Quarta-feira, 13 Novembro 2024

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

Quarta-feira, 13 Novembro 2024

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points

Terça-feira, 12 Novembro 2024

UK stock market news: Helium One share price trading 16.1% higher

Terça-feira, 12 Novembro 2024

Leveraged ETF to package Warren Buffett's Berkshire Hathaway B stock

Terça-feira, 12 Novembro 2024

Dogecoin surges 20% after Department of Government Efficiency announcement

Terça-feira, 12 Novembro 2024

Dow Jones Dips Ahead of CPI Inflation Data; Tesla shares up

Ver todas as notícias
Trustpilot
Live Chat